Biblio
Analysis of early clinical signs and risk factors for severe hemorrhagic cystitis after stem cell transplantation in children. Int J Urol. 2024.
. Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway. J Immunol Res. 2023;2023:3291137.
. Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells. Small Methods. 2021;5(7):e2100071.
CD38-Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells. Adv Sci (Weinh). 2023:e2207394.
A collagen microchannel scaffold carrying paclitaxel-liposomes induces neuronal differentiation of neural stem cells through Wnt/β-catenin signaling for spinal cord injury repair. Biomaterials. 2018;183:114-127.
Correction: TET2 deficiency promotes MDS-associated leukemogenesis. Blood Cancer J. 2023;13(1):174.
Current status and development trend of miRNAs in osteoporosis-related research: A bibliometric analysis. Folia Histochem Cytobiol. 2021.
. Genome-wide identification and expression analysis of GA20ox and GA3ox genes during pod development in peanut. PeerJ. 2023;11:e16279.
. HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML. Aging (Albany NY). 2020;12.
Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection. Leukemia. 2023.
The Major Reverse Transcriptase-Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis. Cancer Res. 2013.
. [Mechanisms of stem cell-derived extracellular vesicles protecting Leydig cells from acute oxidative injury in rats]. Zhonghua Nan Ke Xue. 2018;24(1):14-18.
. . Molecular network mechanism in cerebral ischemia-reperfusion rats treated with human urine stem cells. Heliyon. 2024;10(7):e27508.
. Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway. Pharmaceuticals (Basel). 2023;16(10).
A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation. Bone Marrow Transplant. 2023.
. Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2. Cell Rep. 2022;38(4):110253.
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring Rearrangement and Its Prognostic Factors. Cell Transplant. 2024;33:9636897231225821.
Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia. Nat Cell Biol. 2024.
Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy. J Transl Med. 2023;21(1):456.
. . .